FDA approves insulin injection pens from Novo Nordisk

11/5/2013 | MedGadget.com

The FDA has granted Novo Nordisk approval for a pair of its insulin injection pens -- the NovoLog FlexTouch and the Levemir FLexTouch. The devices, slated for U.S. release next year, are each prefilled with 300 units of insulin and work with the company's NovoFine and NovoTwist needles. The pens were approved in Europe two years ago.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA